← FDA DRUG APPROVALS

FDA NDA · NDA011123

VESPRIN

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
NDA011123
TYPE
NDA
ORIGINAL APPROVAL
1957-09-16
LATEST ACTION
1957-09-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

VESPRINDiscontinued
TRIFLUPROMAZINE HYDROCHLORIDE 50MG · TABLET · ORAL
VESPRINDiscontinued
TRIFLUPROMAZINE HYDROCHLORIDE 10MG · TABLET · ORAL
VESPRINDiscontinued
TRIFLUPROMAZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

1957-09-16Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →